Ready to transform your body and health? Our exclusive 3-Month Weight Loss Program feature

Semaglutide

a powerful prescription medication initially developed for diabetes management and now used to aid weight loss. Semaglutide mimics the action of a hormone called GLP-1 (glucagon-like peptide-1), which helps regulate appetite and food intake. By enhancing the effects of GLP-1, Semaglutide helps you feel fuller for longer and reduces cravings, making it easier to manage your

weight. On average, patients have seen significant weight loss of up to 15-20% of their total body weight with this medication. Additionally, GLP-1 medications have been shown to improve blood sugar control, support heart health by reducing cardiovascular risk factors, and may even aid in lowering blood pressure.

Here’s what you get:

3 months of provider-supervised Semaglutide treatment with once-weekly injections. You can choose to take the medication home and self-administer, or we’ll be happy to administer it for you. This medication helps control appetite and supports weight loss.
Personalized nutrition and fitness guidance to optimize your results.
Comprehensive INBODY body composition analysis to track fat loss, muscle gain, and overall progress.
Ongoing support and check-ins to keep you motivated and on track.

Take the first step toward a healthier, more confident you. Join our program today and watch the pounds melt away!

Semaglutide Q & A

Semaglutide (available under brand names like Wegovy®™ and Ozempic®™) is an FDA-approved medication that mimics the GLP-1 hormone naturally produced in your intestines. It works by reducing appetite and cravings, slowing stomach emptying to increase feelings of fullness, and improving blood sugar regulation. This triple-action approach targets the brain's hunger centers, helping you naturally consume fewer calories.
Ideal candidates are adults with either a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as hypertension or prediabetes. Candidates should be committed to lifestyle modifications including diet and exercise, not pregnant or nursing, and have no personal or family history of medullary thyroid cancer or pancreatitis. Final eligibility is determined during a comprehensive medical consultation.
Clinical studies demonstrate that patients using semaglutide consistently lose an average of 12–15% of their total body weight over 12–16 months. Most patients achieve an initial 5–10% weight reduction within the first three months. Individual results vary based on factors like dosage, metabolic rate, and adherence to lifestyle recommendations.
Semaglutide is administered through weekly self-injections using a very fine needle, with injection sites including the stomach, thigh, or upper arm. Our medical team starts patients at a low dose and gradually increases it to minimize potential side effects. We provide thorough training during your consultation to ensure comfortable and correct at-home administration.
Common temporary side effects include mild nausea, constipation, or diarrhea, which typically resolve within a few weeks as your body adjusts. Rare but serious risks include pancreatitis or gallbladder issues. Our providers personalize dosing schedules and offer anti-nausea protocols to help manage any discomfort effectively.
Significant results typically require a minimum commitment of 3–6 months, though many patients achieve optimal outcomes with 12+ months of treatment. To maintain results, we develop personalized long-term plans that may include reduced dosing alongside nutritional support and behavioral coaching.
Studies indicate approximately 50% of lost weight may return after discontinuation if healthy habits aren't maintained. To prevent rebound weight gain, we design customized tapering protocols and maintenance plans that integrate sustainable nutrition strategies and ongoing medical support.

Trizepatide

An advanced prescription medication that harnesses the power of dual hormone action to support weight loss. Trizepatide mimics the effects of two key hormones—GLP-1 and GIP—that help regulate appetite and food intake. y enhancing these hormones' natural functions, B Trizepatide helps you feel fuller longer and reduces cravings, making it easier to manage your

weight. On average, patients experience significant weight loss of up to 20-25% of their body weight. Additionally, Trizepatide improves blood sugar control, supports heart health by reducing cardiovascular risk factors, and may help lower blood pressure. It also generally has fewer adverse effects and better tolerated compared to single-acting GIP medications.

Here’s what you get:

3 months of provider-supervised Trizepatide treatment with once-weekly injections. You can choose to take the medication home and self-administer, or we are happy to administer it for you.
Personalized nutrition and fitness guidance to maximize your results.
Comprehensive INBODY body composition analysis to track fat loss, muscle gain, and overall progress.
Ongoing support and check-ins to keep you motivated and on track.

Take the first step toward a healthier, more confident you. Join our program today and watch the pounds melt away!

Tirzepatide Q & A

Tirzepatide (marketed as Zepbound™ for weight loss and Mounjaro®™ for type 2 diabetes) is an FDA-approved injectable medication that activates both GLP-1 and GIP hormone receptors. This dual-action approach suppresses appetite, slows gastric emptying to prolong fullness, enhances insulin sensitivity, and reduces fat storage—resulting in significant, sustainable weight reduction.
This treatment is suitable for adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who have at least one weight-related health condition such as hypertension, high cholesterol, or prediabetes. Candidates must have no history of medullary thyroid cancer, pancreatitis, or severe gastrointestinal disease, which our medical team will screen for during your consultation.
Clinical trials demonstrate that Tirzepatide achieves superior weight loss results: Patients using the highest dose (15mg) lost an average of 20–25% of their body weight over 18 months—nearly double the average loss seen with GLP-1-only medications like Semaglutide.
Tirzepatide is self-administered as a weekly subcutaneous injection using a pre-filled pen. Our clinical team will train you on proper injection techniques (abdomen, thigh, or upper arm) during your initial visit. Dosing starts low (2.5mg/week) and gradually increases every 4 weeks to maximize tolerance and effectiveness.
Common temporary side effects include nausea, diarrhea, constipation, and occasional vomiting—typically mild and resolving within weeks. Rare but serious risks include pancreatitis, gallbladder issues, and hypoglycemia. We proactively manage side effects through personalized dosing strategies and dietary guidance.
Most patients report reduced appetite within the first 1–2 weeks. Clinically significant weight loss (5–8% of body weight) typically occurs within 3 months, with peak results achieved after 12–18 months of consistent treatment alongside lifestyle modifications.
Like most metabolic medications, weight regain is possible if treatment is discontinued without a maintenance plan. Our program includes tapering protocols and long-term lifestyle coaching to help preserve results. Studies show patients maintain >80% of lost weight 1 year post-treatment when following our integrated maintenance strategy.

Ready for Transformative Weight Loss? Let Our Experts Guide Your Journey

Whether you’re considering breakthrough medications like Semaglutide or Tirzepatide, Thrive Med Spa VA crafts fully personalized weight loss plans backed by medical expertise. We don’t just prescribe—we partner with you through testing, dosing, and lifestyle coaching to ensure lasting success.

Speak to Our Weight Loss Team: Call (540) 690-9249 or Schedule Your Personalized Consultation Online